Investor Relations

Stock chart for: MJN.  Currently trading at $100.05 with a 52 week high of $105.45 and a 52 week low of $81.23.

Data Provided by Thomson Reuters

NYSE | MJN (Common Stock)


 0.74 (0.75%)


03/27/15  4:01 p.m. ET

Minimum 20 minute delay

Latest News


Mead Johnson Chief Financial Officer Peter G. Leemputte to Step Down

GLENVIEW, Ill.--(BUSINESS WIRE)--Mar. 4, 2015-- Mead Johnson Nutrition Company (NYSE: MJN) announced today that Peter G. Leemputte, its Executive Vice President and Chief Financial Officer, has decided to leave the company for pe

Read More


Mead Johnson Nutrition Increases Size of Board and Names Michael Sherman as Director

GLENVIEW, Ill.--(BUSINESS WIRE)--Mar. 3, 2015-- Mead Johnson Nutrition Company (NYSE: MJN) announced that, at its meeting last week, the Board of Directors increased the maximum size of the board from 12 to 13 and appointed Micha

Read More

MJN: Positioned for Superior Value Creation

  • A leading global brand trusted by consumers and healthcare professionals
  • Uncompromising commitment to scientific rigor and product quality
  • Attractive long-term category growth fundamentals
  • Focused on driving sustainable, profitable long-term growth
  • Strong cash flow to fund growth initiatives

Investor Contact Information

Investor inquiries should be directed to:

Kathy MacDonald

Kathy MacDonald

E-mail Alerts

Sign up to receive e-mail alerts whenever Mead Johnson Nutrition posts new information to the site. Just enter your e-mail address and click Submit.


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.